{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:18:23Z","timestamp":1792163903779,"version":"4.4.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/0253-7613.144943","type":"journal-article","created":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T03:27:51Z","timestamp":1416281271000},"page":"655","source":"Crossref","is-referenced-by-count":17,"title":["A case of etizolam dependence"],"prefix":"10.4103","volume":"46","author":[{"given":"Bhavuk","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.144943-1","first-page":"S52","volume-title":"New developments in the pharmacological treatment of anxiety","author":"Leonard","year":"1999","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"key-10.4103\/0253-7613.144943-2","first-page":"31","volume-title":"Low tolerance and dependence liabilities of etizolam: Molecular, functional, and pharmacological correlates","author":"Sanna","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/0253-7613.144943-3","unstructured":"Sartorius N. The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization; 2004."},{"key":"key-10.4103\/0253-7613.144943-4","first-page":"430","volume-title":"Inclusion of thienodiazepines in prescription rate of anxiolytics","author":"Toda","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"key":"key-10.4103\/0253-7613.144943-5","first-page":"202","volume-title":"Prevention of overlapping prescriptions of psychotropic drugs by community pharmacists","author":"Shimane","year":"2012","journal-title":"Nihon Arukoru Yakubutsu Igakkai Zasshi"},{"key":"key-10.4103\/0253-7613.144943-6","first-page":"705","volume-title":"Approval of new nervous system drugs in India compared with the US and EU","author":"Kataria","year":"2012","journal-title":"Int J Pharm Pharm Sci"},{"key":"key-10.4103\/0253-7613.144943-7","first-page":"41","volume-title":"IPS multicentric study: Antidepressant prescription patterns","author":"Grover","year":"2013","journal-title":"Indian J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5545","issn-type":"print"},{"key":"key-10.4103\/0253-7613.144943-8","first-page":"34","volume-title":"Etizolam-induced superficial erythema annulare centrifugum","author":"Kuroda","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/0253-7613.144943-9","first-page":"506","volume-title":"Etizolam and benzodiazepine induced blepharospasm","author":"Wakakura","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0253-7613.144943-10","first-page":"605","volume-title":"Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic","author":"Nakao","year":"2006","journal-title":"Psychiatry Clin Neurosci"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:05:19Z","timestamp":1786633519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.144943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"alternative-id":["144943"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.144943","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}